Johnson & Johnson (JNJ) reported Q1 adjusted earnings Tuesday of $2.77 per diluted share, up from $2.71 a year earlier.

Analysts polled by FactSet expected $2.58.

Revenue for the quarter ended March 31 was $21.89 billion compared with $21.38 billion a year earlier.

Analysts surveyed by FactSet expected $21.56 billion.

The company reiterated its 2025 adjusted earnings guidance of $10.50 to $10.70 per diluted share. Analysts surveyed by FactSet expect $10.44.